Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01605
J Biol Chem. 2019 Sep 13;294(37):13708-13717. doi: 10.1074/jbc.RA119.008765. Epub 2019 Jul 24.
Dozens of mutations throughout the sequence of the gene encoding superoxide dismutase 1 (SOD1) have been linked to toxic protein aggregation in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). A parsimonious explanation for numerous genotypes resulting in a common phenotype would be mutation-induced perturbation of the folding free-energy surface that increases the populations of high-energy states prone to aggregation. The absence of intermediates in the folding of monomeric SOD1 suggests that the unfolded ensemble is a potential source of aggregation. To test this hypothesis, here we dissected SOD1 into a set of peptides end-labeled with FRET probes to model the local behavior of the corresponding sequences in the unfolded ensemble. Using time-resolved FRET, we observed that the peptide corresponding to the Loop VII-β8 sequence at the SOD1 C terminus was uniquely sensitive to denaturant. Utilizing a two-dimensional form of maximum entropy modeling, we demonstrate that the sensitivity to denaturant is the surprising result of a two-state-like transition from a compact to an expanded state. Variations of the peptide sequence revealed that the compact state involves a nonnative interaction between the disordered N terminus and the hydrophobic C terminus of the peptide. This nonnative intramolecular structure could serve as a precursor for intermolecular association and result in aggregation associated with ALS. We propose that this precursor would provide a common molecular target for therapeutic intervention in the dozens of ALS-linked SOD1 mutations.
数十种突变贯穿编码超氧化物歧化酶 1(SOD1)的基因序列,这些突变与神经退行性疾病肌萎缩性侧索硬化症(ALS)中的毒性蛋白聚集有关。众多基因型导致常见表型的简约解释可能是突变诱导的折叠自由能表面的扰动,增加了易于聚集的高能状态的种群。单体 SOD1 折叠过程中没有中间体,这表明未折叠的整体是聚集的潜在来源。为了验证这一假设,我们在这里将 SOD1 分解成一组肽,这些肽用 FRET 探针进行末端标记,以模拟未折叠整体中相应序列的局部行为。使用时间分辨的 FRET,我们观察到 SOD1 C 末端对应 Loop VII-β8 序列的肽对变性剂具有独特的敏感性。利用二维最大熵建模的形式,我们证明对变性剂的敏感性是从紧凑状态到扩展状态的类似两态转变的出人意料的结果。肽序列的变化表明,紧凑状态涉及无规 N 末端和肽的疏水性 C 末端之间的非天然相互作用。这种非天然的分子内结构可能作为分子间缔合的前体,并导致与 ALS 相关的聚集。我们提出,这种前体将为数十种与 ALS 相关的 SOD1 突变提供治疗干预的共同分子靶点。